Author

Jingyi Guo

Observed name: J Guo

Institutions: China Pharmaceutical University, Nanjing Drum Tower Hospital, Nanjing University

Observed institutions: Northwest Minzu University, China Pharmaceutical University, Guangxi Minzu University, Ningxia Hui Autonomous Region Peoples Hospital, Nanjing Drum Tower Hospital, Nanjing University

ORCID: 0000-0003-0215-2895

Observed ORCID: 0000-0003-0215-2895

OpenAlex ID: A5038014724

First Report of Epicoccum latusicollum Causing Leaf Blight on Curcuma kwangsiensis in China

2023 · Hanyi Wang, Yunping Shi, et al. · Plant Disease · 10

Survival benefit and biomarker of PD‐1 inhibitor combination therapy in first‐line of advanced biliary tract cancer: A retrospective study

2023 · Jingyi Guo, Qun Zhou, et al. · Cancer Medicine · 6

Esophageal cancer-related gene 4 and solid tumors: a brief literature review.

2022 · X Li, P Wang, et al. · PubMed · 6

Anti-MSLN chimeric antigen receptor-like NK cell therapy with tumor-penetrating capacity (uCAR-like NK) for solid tumors

2025 · Mengchao An, Ying Wang, et al. · Signal Transduction and Targeted Therapy · 2

De novo design of a two-step approach targeting Claudin-6 for enhanced drug delivery to solid tumors

2025 · Jiayao Yan, Liqing Zhong, et al. · Journal of Translational Medicine · 1

Identification of Fusarium sacchari Causing Foliar Blight on Begonia semperflorens in China

2023 · Siyu Lin, Ze Liu, et al. · Plant Disease · 1

Novel tetrameric bispecific KK-LC-1×CD16A-armed memory-like NK cells enhance antitumor efficacy in gastric cancer

2025 · Mengzhu Li, Tianran Chen, et al. · Journal for ImmunoTherapy of Cancer

Works count: 7

Citation count: 26

H-index: 3

I10-index: 1